Biocryst Pharmaceuticals (BCRX) EPS (Basic): 2010-2015
Historic EPS (Basic) for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to -$0.20.
- Biocryst Pharmaceuticals' EPS (Basic) fell 66.67% to -$0.20 in Q3 2015 from the same period last year, while for Sep 2015 it was -$0.50, marking a year-over-year increase of 18.03%. This contributed to the annual value of -$0.68 for FY2014, which is 23.64% down from last year.
- Latest data reveals that Biocryst Pharmaceuticals reported EPS (Basic) of -$0.20 as of Q3 2015, which was down 385.71% from $0.07 recorded in Q2 2015.
- Biocryst Pharmaceuticals' EPS (Basic)'s 5-year high stood at $0.07 during Q2 2015, with a 5-year trough of -$0.32 in Q3 2011.
- In the last 3 years, Biocryst Pharmaceuticals' EPS (Basic) had a median value of -$0.16 in 2014 and averaged -$0.14.
- In the last 5 years, Biocryst Pharmaceuticals' EPS (Basic) crashed by 88.89% in 2014 and then surged by 130.43% in 2015.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' EPS (Basic) stood at -$0.29 in 2011, then increased by 24.14% to -$0.22 in 2012, then skyrocketed by 59.09% to -$0.09 in 2013, then plummeted by 77.78% to -$0.16 in 2014, then tumbled by 66.67% to -$0.20 in 2015.
- Its EPS (Basic) was -$0.20 in Q3 2015, compared to $0.07 in Q2 2015 and -$0.21 in Q1 2015.